Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Mar 1;16(5):1348-54.
doi: 10.1158/1078-0432.CCR-09-2273. Epub 2010 Feb 23.

New Strategies in Kidney Cancer: Therapeutic Advances Through Understanding the Molecular Basis of Response and Resistance

Affiliations
Free article
Review

New Strategies in Kidney Cancer: Therapeutic Advances Through Understanding the Molecular Basis of Response and Resistance

Brian I Rini. Clin Cancer Res. .
Free article

Abstract

The emergence of viable therapeutic strategies in metastatic renal cell carcinoma has invigorated translational and clinical research in this disease. Building upon the clinical activity observed with inhibition of vascular endothelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) pathways, novel strategies are being investigated to extend existing clinical benefits. Preclinical study has identified potential molecular mechanisms of response and resistance, providing a rational basis for biomarker development as well as sequential and combination therapy strategies. Several treatment strategies have emerged that are in the early phases of clinical testing. Further clinical and translational research is needed to validate initial hypotheses and translate observations into novel treatment strategies.

Similar articles

See all similar articles

Cited by 36 articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback